Olema Pharmaceuticals, Inc.

NASDAQ:OLMA

4.67 (USD) • At close May 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -129.474-96.655-104.787-71.096-22.121-4.316-2.197
Depreciation & Amortization 0.3930.3770.3570.1630.0110.0090.008
Deferred Income Tax 0000.276000
Stock Based Compensation 22.58217.25618.82915.9133.10800.001
Change In Working Capital 9.164-0.5893.0222.83-1.5051.226-0.11
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables 2.512.3240.351-0.683-0.221.168-0.1
Other Working Capital 6.654-2.9132.6713.513-1.2850.058-0.01
Other Non Cash Items -7.016-4.1160.5141.2240.641-1.150.122
Operating Cash Flow -104.351-83.727-82.065-50.69-19.866-3.081-2.176
Investing Activities:
Investments In Property Plant And Equipment 00-0.363-1.575-0.05600
Acquisitions Net 000.3631.575000
Purchases Of Investments -394.959-255.625-213.66-486.967000
Sales Maturities Of Investments 301.592250.76305.502213.104000
Other Investing Activites -0.1590.014-0.363-1.575-0.05600
Investing Cash Flow -93.526-4.85191.479-275.438-0.05600
Financing Activities:
Debt Repayment 00003.08800.323
Common Stock Issued 266.288129.7360.330.721220.5505.254
Common Stock Repurchased 0000-2.28900
Dividends Paid 0000000
Other Financing Activities 2.533.6790.4761.391134.76509.862
Financing Cash Flow 268.818133.4150.4761.391358.40305.254
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash 70.94144.8379.89-324.737338.481-3.0813.078
Cash At End Of Period 139.4868.53923.70213.812338.5490.0683.149